RGT

Argent BioPharma publishes Company Presentation for June 2024

Argent BioPharma Limited (ASX:RGT) has released its June 2024 Company Presentation, showcasing its innovative solutions in the biopharmaceutical sector...

July 2, 2024

Argent BioPharma secures $500,000 investment to advance drug development pipeline

Argent BioPharma (LON:RGT) raises $500,000 through a share placement at a 400% premium, boosting drug development for CannEpil® and CimetrA®...

July 1, 2024

Argent BioPharma MD on being a meaningful breakthrough drug discovery company (ASX:RGT)

Roby Zomer, CEO of Argent BioPharma Ltd, discusses the company's restructuring, product portfolio, and outlook in an exclusive interview with DirectorsTalk. Learn more about their focus on drug discovery and biopharma...

May 9, 2024

Argent BioPharma Positive Quarter Activity Report with CEO Roby Zomer (VIDEO)

Discover insights from Argent BioPharma Ltd Managing Director and CEO Roby Zomer on the company's Quarter Activity Report and future outlook in this exclusive interview...

May 2, 2024

MGC Pharmaceuticals formally changes its name to Argent BioPharma Ltd

Argent BioPharma Ltd, formerly MGC Pharmaceuticals Limited, is a pioneering drug discovery company in the biopharmaceutical sector. Learn about their recent name change and impactful advancements in drug development...

April 2, 2024

News and Interview Alerts

Company Presentations

Cerillion Plc Annual KPIs. Substantial Pipeline. Stronger Competitive Position

RECI presentation: High-yielding, controlled-risk lending supports near 10% dividend yield

Q&As

Yü Group backed for strong upside as Premier Miton highlights low valuation and market share gains

9 February 2026

Gervais Williams backs Ithaca Energy for sustained returns and exceptional dividend potential (LON:ITH)

9 February 2026

ACG Metals positioned for strong cash generation and long-term value as copper production ramps up, highlights DIVI fund manager

6 February 2026

BlueNord ASA fund manager expects very substantial cash generation for years

6 February 2026

Hardman & Co

NB Private Equity Partners 2025 CMD: good returns from low-risk PE model

10 December 2025

Real Estate Credit Investments (RECI): Investor Day: opportunities aplenty

2 December 2025

Volta Finance: Liquid access to outperforming private credit

6 October 2025

Real Estate Credit Investments: What RECI brings to investors

15 September 2025

Chesnara Plc: Showing good operational progress

8 September 2025

Green News

Best UK and TSX Energy Shares 2026

9 February 2026

Ilika Plc: Solid-State Breakthroughs Put Stereax and Goliath in the Spotlight (Video)

23 January 2026

View all Sustainable sectors, Plcs and news >>

Search

Latest Interviews

The Diverse Income Trust: Why Gervais Williams Is Doubling Down on Overlooked UK Small Caps (video)

Ilika Plc: Solid-State Breakthroughs Put Stereax and Goliath in the Spotlight (Video)

BrokerTalk

Sintana Energy Strengthens Position with ExxonMobil Settlement, Eyes Growth in 2026 – Auctus Advisors LLP

4 February 2026

Naked Wines Broker Tips Over 120% Price Upside on Profitable Growth – Panmure Liberum

2 February 2026

Alkemy Capital Gains Momentum with Major 5 Year Glencore Deal and Project Financing – Zeus

28 January 2026

Funds

Yü Group backed for strong upside as Premier Miton highlights low valuation and market share gains

9 February 2026

Gervais Williams backs Ithaca Energy for sustained returns and exceptional dividend potential (LON:ITH)

9 February 2026

ACG Metals positioned for strong cash generation and long-term value as copper production ramps up, highlights DIVI fund manager

6 February 2026

BlueNord ASA fund manager expects very substantial cash generation for years

6 February 2026

Primary Health Properties surplus cash fuels generous dividend, Gervais Williams impressed

4 February 2026

View all Funds, Market Insights and news >>

FTSE 100 News

UK Broker Ratings

Vistry Group PLC (VTY.L) Stock Analysis: Navigating a Challenging Residential Market with Strategic Insights

9 February 2026

Standard Chartered PLC (STAN.L) Stock Analysis: Evaluating Growth Amidst Volatility and a 9.72% ROE

9 February 2026

Unilever PLC (ULVR.L) Stock Analysis: Navigating the Consumer Goods Giant’s Market Position and Analyst Ratings

9 February 2026

Weir Group PLC (WEIR.L): Analyst Ratings Highlight Strong Buy Consensus Amidst Impressive Stock Performance

9 February 2026

Reckitt Benckiser Group PLC (RKT.L) Stock Analysis: Navigating a 6.29% Upside Amid Strong ROE

9 February 2026

News

Argent BioPharma publishes Company Presentation for June 2024

Argent BioPharma Limited (ASX:RGT) has released its June 2024 Company Presentation, showcasing its innovative solutions in the biopharmaceutical sector...

July 2, 2024

Argent BioPharma secures $500,000 investment to advance drug development pipeline

Argent BioPharma (LON:RGT) raises $500,000 through a share placement at a 400% premium, boosting drug development for CannEpil® and CimetrA®...

July 1, 2024

Argent BioPharma MD on being a meaningful breakthrough drug discovery company (ASX:RGT)

May 9, 2024

Argent BioPharma Positive Quarter Activity Report with CEO Roby Zomer (VIDEO)

Discover insights from Argent BioPharma Ltd Managing Director and CEO Roby Zomer on the company's Quarter Activity Report and future outlook in this exclusive interview...